Issues associated with use of strontium-89 and other beta emitting radiopharmaceuticals.

Issues associated with use of strontium-89 and other beta emitting radiopharmaceuticals.

Bibliographic Details
Corporate Author: U.S. Nuclear Regulatory Commission. Office of Nuclear Material Safety and Safeguards
Format: Government Document eBook
Language:English
Published: Washington, DC : U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards, [1994]
Series:NRC information notice ; 94-70.
Subjects:
Strontium > Physiological effect.
Radiopharmaceuticals.
Beta rays > Physiological effect.
Online Access:https://purl.fdlp.gov/GPO/gpo9468

Internet

https://purl.fdlp.gov/GPO/gpo9468

Available Online

Holdings details from Available Online
Call Number: Y 3.N 88:56-2/94-70
 
Call Number Status Get It
Y 3.N 88:56-2/94-70 Available